Roche to acquire molecular diagnostic solutions firm GenMark Diagnostics

Roche has agreed to acquire US-based molecular diagnostic solutions provider GenMark Diagnostics for $24.05 per share or about $1.8 billion in an all-cash deal. GenMark ... Read More